Search

everythinglearnresearchcommunity

for

Search:↓

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Severe alopecia areata may increase the risk of heart-related diseases.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Ayurvedic treatment successfully regrew hair in a woman with alopecia areata.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

The guideline provides recommendations for managing alopecia areata effectively.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Baricitinib works better than methotrexate for severe alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Alopecia areata may be linked to higher heart disease risk.

Disease-specific tools better assess quality of life in alopecia areata patients.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Higher IL-19 levels are linked to more severe Alopecia Areata.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Apremilast showed mixed results for treating severe alopecia areata.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.